COVID-19 has had a mixed impact on pharmaceutical drugs


London, December 16, 2020 (GLOBE NEWSWIRE) – TBRC’s annual festive sale has finally arrived! Get up to 50% off ALL reports:

According to The Business Research Company’s research report on Pharmaceutical Drugs and Biologics Logistics Market, the coronavirus outbreak that has taken the world has had a mixed impact on the pharmaceutical logistics market. Supply chain restrictions resulting from the COVID-19 pandemic have had an impact on the biologics logistics industry. However, the need for essential pharmaceutical supplies during the COVID-19 pandemic is positively impacting the market and is expected to drive the market as the pandemic continues. The specific requirements for the storage and transport of pharmaceuticals and vaccines make the logistics of pharmaceuticals and biologicals complex.

During the crisis, several initiatives taken by the main players in the industry and collaborations between players in pharmaceutical and biological logistics and pharmaceutical players have supported the growth of the market. Government intervention to speed up the COVID-19 testing process and initiatives to provide essential pharmaceuticals to patients during the pandemic have also had a positive impact on the market.

The global drug and biologics logistics market size has reached a value of nearly $ 90.30 billion in 2020, having grown at a compound annual growth rate (CAGR) of 4.1% since 2015. The market is expected to reach $ 102.89 billion by 2025, and $ 130.03 billion by 2030. North America was the largest region in the global pharmaceutical logistics market, representing 47.9% of the total in 2020. It was followed by Asia-Pacific, Western Europe, and then other regions. Going forward, the fastest growing regions in the pharmaceutical drugs and biologics logistics market will be South America and Africa, where growth will be at CAGRs of 6.0% and 4.6% respectively.

The commercial research company‘s report titled Drug and Pharmaceutical Biologics Logistics Market – Opportunities and Strategies – Global Forecast to 2030 Covers Major Drug and Biologics Logistics Companies, Drug and Biologics Logistics Market Share by Company, Pharmaceuticals and Biologics Logistics Product Manufacturers, Logistics Infrastructure Market Size Pharmaceuticals and Biologics and Pharmaceuticals and Biologics Logistics Market Forecast. The report also covers the global pharmaceutical drugs and biologics logistics market and its segments.

Global Pharmaceutical Drugs and Biologics Logistics Sample Request Market report:

The growing demand for heat sensitive biopharmaceuticals such as vaccines and blood plasma products is expected to drive the market for pharmaceutical drugs and biologics logistics. This is especially the case now that the COVID-19 vaccine is being distributed. Many pharmaceuticals are temperature controlled and a small fluctuation in temperature / ventilation due to irregular power supply can damage the cargo. This results in the need for temperature-controlled or cold chain transport. In addition, an increasing supply of drugs from drug manufacturers will also increase the demand for logistics services. In March 2020, LGM Pharma said biopharmaceuticals are expected to account for nearly 50% of the value of the world’s top 100 pharmaceuticals this year. In terms of logistics, biopharmaceuticals are more demanding and require precise temperature control throughout the supply chain, from manufacturer to patient. This would mean multiple changes in control from truckers and carriers, through freight forwarders and agents, to distributors and pharmacies. With the evolution of manufactured drugs, the need for temperature control in the supply chain has increased. The increase in the manufacture of biologics and biosimilars is also expected to contribute to the growth of the pharmaceutical drugs and biologics logistics market.

Medicines and Pharmaceutical Biologics Logistics Market – By Type (Cold Chain Logistics and Non-Cold Chain Logistics), Transport Mode, Therapeutic Area and Region, Opportunities and Strategies – Global Forecast to 2030 is part of a series of new reports from The commercial research company which provide market overviews, analyze and forecast market size and growth for the overall market, segments and geographies, trends, drivers, restraints, revenue, profiles and market share from leading competitors in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies. The report also gives an in-depth analysis of the impact of COVID-19 on the market. The reports are backed by 150,000 datasets, in-depth secondary research and proprietary information from interviews with industry leaders. A team of highly experienced and expert analysts and modelers provide market analysis and forecast. The reports identify major countries and segments for opportunities and strategies based on market trends and approaches of major competitors.

Here is a list of similar reports from Business Research Company:

Pharmaceuticals Market – By Type (Pharmaceutical Drugs, Biologics), By Pharmaceutical Drugs Type (Cardiovascular Drugs, Dermatological Drugs, Gastrointestinal Drugs, Genitourinary Drugs, Hematological Drugs, Anti-infective Drugs, Drugs for Metabolic Disorders, drugs for musculoskeletal disorders, central nervous system Systemic drugs, oncology drugs, ophthalmologic drugs, drugs for respiratory diseases), by type of biologic drugs (monoclonal antibodies (MAb), therapeutic proteins, vaccines) and by region, opportunities and strategies – Global forecasts until 2030

Global Biologics Market – By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or PI)), By Drug Classification (Brand Name Drugs, Generic Drugs), By Mode Of Delivery Procurement (Prescription Drugs, Over-the-Counter Drugs), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region, Opportunities and Strategies – Global Forecast to 2023

Supply Chain Management Software Market – By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combination Drugs, Others), By Disease Type (Open Angle Glaucoma, Closed Angle Glaucoma, normal tension glaucoma, congenital glaucoma, other types of glaucoma), by prescription type (over-the-counter drugs, prescription drugs) and by region, opportunities and strategies – Global forecast to 2030

Want to learn more about The Business Research Company?

The Business Research Company is a market intelligence company that excels in business, market and consumer research. With offices around the world, it has consultants who specialize in a wide range of industries, including manufacturing, healthcare, financial services, chemicals and technology.

The most comprehensive database in the world

The flagship product of The Business Research Company, Global market model, is a market information platform covering various macroeconomic indicators and measures in 60 geographies and 27 sectors. The global market model covers multi-layered data sets that help its users to assess the gaps between supply and demand.


Comments are closed.